Sion B, Saint Dizier E, Duval J, Thieulant M L
CNRS URA 256, Laboratoire d'Endocrinologie Moléculaire, Campus de Beaulieu, 35042 Rennes Cédex, France.
Neurochem Int. 1989;15(3):277-83. doi: 10.1016/0197-0186(89)90133-2.
The gonadotrope polypeptide (GP87), a secretogranin II form, has previously been found to be co-released with luteinizing hormone (LH) by rat gonadotrope cells under luteinizing hormone-releasing hormone (LHRH) stimulation. Nothing is hitherto known concerning its function and regulation. In the present paper, the modulatory effects of steroids on GP87 release were investigated using cultures of rat pituitary cell aggregates. As steroid effects are dependent on the presence of receptors, we firstly demonstrated that the steroid receptors are maintained with their typical characteristics in this culture system. In steroid-free medium, the estrogen receptor concentration increased significantly (P < 0.01) within 7 days in culture (646 +/- 122 fmol/mg DNA, n = 3) when compared to the level in freshly dispersed cells (355 +/- 59 fmol/mg DNA, n = 4) suggesting that cells can synthesize the estrogen receptor and that this cell culture system is suitable for studying regulatory effects of steroids. Pituitary cell aggregates from 14 day-old female rats were maintained for 24 h in the absence or presence of 10 nM estradiol (E(2)) or 50 nM 5?-dihydrotestosterone (DHT) and incubated for 2.5 h with [(35)S] methionine. Perifusion was initiated and 4 min pulses of 20 nM LHRH occurred every 1 h. The effects of steroids were investigated on LH, total and labeled GP87. The results indicated that: (1) DHT pretreatment reduced the amplitude of LHRH-stimulated GP87 and LH release responses; (2) by contrast, E(2) pretreatment enhanced the effects of LHRH on total or labeled GP87 release whereas the LH release was not significantly modified; and (3) when E(2) treatment started only 60 min before the first LHRH pulse, no differences between responses of E(2)-treated and control aggregates were observed. The present data show for the first time that sex steroids can modulate the GP87 release through a direct effect on the pituitary. E(2) could either stimulate the GP87 synthesis or increase its intracellular trafficking. That LH and GP87 do not strictly exhibit the same release response further suggests either some heterogeneity of GP87 localization in gonadotrope sub-types or within secretory granules.
促性腺激素细胞多肽(GP87)是嗜铬粒蛋白II的一种形式,先前已发现它在促黄体生成素释放激素(LHRH)刺激下,由大鼠促性腺激素细胞与促黄体生成素(LH)共同释放。迄今为止,对其功能和调节尚一无所知。在本文中,我们使用大鼠垂体细胞聚集体培养物研究了类固醇对GP87释放的调节作用。由于类固醇的作用依赖于受体的存在,我们首先证明了在该培养系统中类固醇受体保持其典型特征。在无类固醇培养基中,与新鲜分散细胞(355±59 fmol/mg DNA,n = 4)中的水平相比,培养7天内雌激素受体浓度显著增加(P < 0.01)(646±122 fmol/mg DNA,n = 3),这表明细胞可以合成雌激素受体,并且这种细胞培养系统适合于研究类固醇的调节作用。将14日龄雌性大鼠的垂体细胞聚集体在不存在或存在10 nM雌二醇(E₂)或50 nM 5α-二氢睾酮(DHT)的情况下维持24小时,并用[³⁵S]甲硫氨酸孵育2.5小时。开始灌流,每1小时出现20 nM LHRH的4分钟脉冲。研究了类固醇对LH、总GP87和标记的GP87的影响。结果表明:(1)DHT预处理降低了LHRH刺激的GP87和LH释放反应的幅度;(2)相比之下,E₂预处理增强了LHRH对总GP87或标记的GP87释放的作用,而LH释放没有显著改变;(3)当E₂处理仅在第一个LHRH脉冲前60分钟开始时,未观察到E₂处理的聚集体和对照聚集体的反应之间存在差异。目前的数据首次表明,性类固醇可通过对垂体的直接作用来调节GP87的释放。E₂可能刺激GP87的合成或增加其细胞内运输。LH和GP87并不严格表现出相同的释放反应,这进一步表明GP87在促性腺激素细胞亚型中或分泌颗粒内存在一些异质性。